Taiwan hosts 11th Smart City Summit & Expo, showcasing global innovations 20-03-2024, 16:20

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26

Quartus Capital Partners is Delighted to Announce the Final Closing of Quartus AI Fund LP with $50 Million Plus in Commitments 14-07-2025, 21:00